Egrifta Prices, Coupons and Patient Assistance Programs
Egrifta (tesamorelin) is a member of the growth hormones drug class and is commonly used for Lipodystrophy.
The cost for Egrifta subcutaneous powder for injection 2 mg is around $6,041 for a supply of 30 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Egrifta price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Subcutaneous Powder For Injection
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.Print Free Discount Card
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Egrifta Coupons and Rebates
Egrifta offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Egrifta SV Co-Pay Assistance Program: Eligible commercially insured patients may save on their prescriptions by enrolling in the program; contact a Patient Support Specialist for additional information at 833-238-4372.
|Applies to:||Egrifta SV|
|Number of uses:||12 times within calendar year|
Patient Assistance Programs for Egrifta
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: THERA Patient Support ProgramElligibility requirements:
- Contact program for details.
- Not disclosed
- Medically appropriate condition/diagnosis
- The patient must be a US citizen or legal resident.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. Education and support services are available; Contact program for details.
- Egrifta SV (tesamorelin) Injection; Subcutaneous
More about Egrifta (tesamorelin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- 13 Reviews
- Drug class: growth hormones
- FDA Approval History